跳至主要内容
临床试验/ISRCTN76129839
ISRCTN76129839已完成未知

Comparison of the efficacy and safety of aspirin and rivaroxaban following enoxaparin treatment for prevention of VTE after hip fracture surgery

Department of Orthopedic Surgery, West China Hospital, Sichuan University0 个研究点目标入组 390 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
390

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Hip fracture who were diagnosed by X-ray and/or computed tomography.

排除标准

  • 1. Lower extremity DVT confirmed by preoperative ultrasonography
  • 2. History of thromboembolic disease and undergoing anticoagulant therapy
  • 3. Presence of hemorrhagic diseases and/or a major bleeding history
  • 4. Severe liver or kidney diseases
  • 5. Coagulation disorders
  • 6. Allergy to enoxaparin, aspirin, or rivaroxaban
  • 7. Platelet count less than 100*10^9 cells/L

研究者

发起方
Department of Orthopedic Surgery, West China Hospital, Sichuan University

相似试验